Login / Signup

IκB kinase phosphorylates cytoplasmic TDP-43 and promotes its proteasome degradation.

Yohei IguchiYuhei TakahashiJiayi LiKunihiko ArakiYoshinobu AmakusaYu KawakamiKenta KobayashiSatoshi YokoiMasahisa Katsuno
Published in: The Journal of cell biology (2024)
Cytoplasmic aggregation of TDP-43 in neurons is a pathological feature common to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). We demonstrate that the IκB kinase (IKK) complex promotes the degradation of cytoplasmic TDP-43 through proteasomes. While IKKβ is a major factor in TDP-43 degradation, IKKα acts as a cofactor, and NEMO functions as a scaffold for the recruitment of TDP-43 to the IKK complex. Furthermore, we identified IKKβ-induced phosphorylation sites of TDP-43 and found that phosphorylation at Thr8 and Ser92 is important for the reduction of TDP-43 by IKK. TDP-43 phosphorylation at Ser92 was detected in a pattern different from that of C-terminal phosphorylation in the pathological inclusion of ALS. IKKβ was also found to significantly reduce the expression level and toxicity of the disease-causing TDP-43 mutation. Finally, the favorable effect of IKKβ on TDP-43 aggregation was confirmed in the hippocampus of mice. IKK and the N-terminal phosphorylation of TDP-43 are potential therapeutic targets for ALS and FTLD.
Keyphrases
  • amyotrophic lateral sclerosis
  • protein kinase
  • machine learning
  • oxidative stress
  • metabolic syndrome
  • adipose tissue
  • insulin resistance
  • blood brain barrier
  • drug induced
  • binding protein
  • subarachnoid hemorrhage